Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: Ariella who wrote (1250)	9/17/1998 11:28:00 PM
From: wolfdog2	Read Replies (1) \| Respond to of 1491

Ariella, I would like to join the chorus thanking you for an excellent report. I suspect that today's weakness in the stock, if it was indeed related to PARS and not merely to market dynamics, had more to do with the prediction of reduced Q3 revenues than HU 211. Viewing PARS as an operating company, revenues are key--at least until there are earnings. Eventually, both earnings and revenues will play a key role in determining the stock's price. As to moving the thread, I doubt that it would make much difference one way or the other.